Showing results (31-40 of 1,896) with videos related to
Sort By:
Pageof 190
Journal of Immunology (Baltimore, Md. : 1950)|April 1, 1981
The immunologic response in mice unresponsive to experimental allergic encephalomyelitisZ Lando, D Teitelbaum, R ArnonJournal of Immunology (Baltimore, Md. : 1950)|November 1, 1979
Effect of cyclophosphamide on suppressor cell activity in mice unresponsive to EAEZ Lando, D Teitelbaum, R ArnonCellular and Molecular Life Sciences : CMLS|January 1, 1997
Copolymer 1: from basic research to clinical applicationD Teitelbaum, R Arnon, M SelaJournal of Neurology|April 1, 1996
New insights into the mechanism of action of copolymer 1 in experimental allergic encephalomyelitis and multiple sclerosisR Arnon, M Sela, D TeitelbaumJournal of Neural Transmission. Supplementum|January 1, 1997
Cop 1 as a candidate drug for multiple sclerosisD Teitelbaum, R Arnon, M SelaEuropean Journal of Biochemistry|May 6, 1975
Immunological comparison of basic encephalitogen and histone F2A1M Bustin, D Teitelbaum, C WebbProceedings of the National Academy of Sciences of the United States of America|March 31, 1999
Immunomodulation of experimental autoimmune encephalomyelitis by oral administration of copolymer 1D Teitelbaum, R Arnon, M SelaEuropean Journal of Immunology|January 1, 1993
T suppressor hybridomas and interleukin-2-dependent lines induced by copolymer 1 or by spinal cord homogenate down-regulate experimental allergic encephalomyelitisR Aharoni, D Teitelbaum, R ArnonJournal of the Neurological Sciences|April 1, 1977
Effect of a synthetic polypeptide (COP 1) on patients with multiple sclerosis and with acute disseminated encephalomeylitis. Preliminary reportO Abramsky, D Teitelbaum, R ArnonIsrael Journal of Medical Sciences|December 1, 1989
Suppression of experimental allergic encephalomyelitis by COP1--relevance to multiple sclerosisR Arnon, D Teitelbaum, M SelaPageof 190